4.7 Article

DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 63, Issue 18, Pages 10224-10234

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.0c00898

Keywords

-

Funding

  1. SGC [1097737]
  2. AbbVie
  3. Bayer Pharma AG
  4. Boehringer Ingelheim
  5. Canada Foundation for Innovation
  6. Eshelman Institute for Innovation
  7. Genome Canada
  8. Janssen
  9. Merck KGaA Darmstadt Germany
  10. MSD
  11. Novartis Pharma AG
  12. Ontario Ministry of Economic Development and Innovation
  13. Pfizer
  14. Sao Paulo Research Foundation-FAPESP
  15. Takeda
  16. Wellcome [532 106169/ZZ14/Z]
  17. EU/EFPIA/OICR/McGill/KTH/Diamond Innovative Medicines Initiative 2 Joint Undertaking [EUbOPEN] [875510]
  18. DFG [SFB1177]
  19. German Translational Cancer Consortium
  20. European Union [730872]

Ask authors/readers for more resources

Selectivity remains a challenge for ATP-mimetic kinase inhibitors, an issue that may be overcome by targeting unique residues or binding pockets. However, to date only few strategies have been developed. Here we identify that bulky residues located N-terminal to the DFG motif (DFG-1) represent an opportunity for designing highly selective inhibitors with unexpected binding modes. We demonstrate that several diverse inhibitors exerted selective, noncanonical binding modes that exclusively target large hydrophobic DFG-1 residues present in many kinases including PIM, CK1, DAPK, and CLK. By use of the CLK family as a model, structural and biochemical data revealed that the DFG-1 valine controlled a noncanonical binding mode in CLK1, providing a rationale for selectivity over the closely related CLK3 which harbors a smaller DFG-1 alanine. Our data suggest that targeting the restricted back pocket in the small fraction of kinases that harbor bulky DFG-1 residues offers a versatile selectivity filter for inhibitor design.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available